Literature DB >> 24945015

Facial nerve palsy, headache, peripheral neuropathy and Kaposi's sarcoma in an elderly man.

Dimitrios Daoussis1, Elisabeth Chroni1, Athanassios C Tsamandas1, Andrew P Andonopoulos1.   

Abstract

We present a case of an elderly man, who initially presented with right facial nerve palsy, ipsilateral headache, elevated erythrocyte sedimentation rate (ESR) and no fever. A presumptive diagnosis of giant cell arteritis was made and the patient was treated with high-dose steroids. A temporal artery biopsy was negative. Several months later, while on 16 mg of methylprednisolone daily, he presented with severe sensorimotor peripheral symmetric neuropathy, muscle wasting and inability to walk, uncontrolled blood sugar and psychosis. A work-up for malignancy was initiated with the suspicion of a paraneoplastic process. At the same time a biopsy of the macular skin lesions that had appeared on the skin of the left elbow and right knee almost simultaneously was inconclusive, whereas a repeat biopsy from the same area of the lesions that had become nodular, a month later, was indicative of Kaposi's sarcoma. Finally, a third biopsy of a similar lesion, after spreading of the skin process, confirmed the diagnosis of Kaposi's sarcoma. He was treated with interferon α and later was seen in very satisfactory condition, with no clinical evidence of neuropathy, normal muscle strength, no headache, normal electrophysiologic nerve studies, involution of Kaposi's lesions and a normal ESR.

Entities:  

Keywords:  Facial nerve palsy; Kaposi’s sarcoma; Paraneoplastic syndrome; Peripheral neuropathy; Vasculitis

Year:  2014        PMID: 24945015      PMCID: PMC4061317          DOI: 10.12998/wjcc.v2.i6.235

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


  11 in total

1.  A Bayesian analysis of the true sensitivity of a temporal artery biopsy.

Authors:  Ryan D Niederkohr; Leonard A Levin
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-02       Impact factor: 4.799

Review 2.  [Neurological involvement in Wegener's granulomatosis].

Authors:  Kunihiko Asakura; Tatsuro Muto
Journal:  Brain Nerve       Date:  2013-11

3.  Eight-and-a-half syndrome: one-and-a-half syndrome plus cranial nerve VII palsy.

Authors:  E Eggenberger
Journal:  J Neuroophthalmol       Date:  1998-06       Impact factor: 3.042

4.  [Peripheral facial paralysis disclosing Horton's disease].

Authors:  B Taillan; J G Fuzibet; H Vinti; J Castela; N Gratecos; P Dujardin; A Pesce
Journal:  Rev Rhum Mal Osteoartic       Date:  1989-03-15

Review 5.  Polyarteritis nodosa revisited.

Authors:  Inés Colmegna; José A Maldonado-Cocco
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

6.  [A case of peripheral facial paralysis in Horton's disease].

Authors:  S Bakchine; D Côte; H Massiou; C Derouesné
Journal:  Presse Med       Date:  1985-11-23       Impact factor: 1.228

7.  [Fisher's one and half syndrome with facial palsy as clinical presentation of giant cell temporal arteritis].

Authors:  I D Zamarbide; M J Maxit
Journal:  Medicina (B Aires)       Date:  2000       Impact factor: 0.653

Review 8.  Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art.

Authors:  A Vaglio; C Buzio; J Zwerina
Journal:  Allergy       Date:  2013-01-18       Impact factor: 13.146

9.  Peripheral neuropathic syndromes in giant cell (temporal) arteritis.

Authors:  R J Caselli; J R Daube; G G Hunder; J P Whisnant
Journal:  Neurology       Date:  1988-05       Impact factor: 9.910

Review 10.  Primary angiitis of the central nervous system and reversible cerebral vasoconstriction syndrome.

Authors:  Tariq A Hammad; Rula A Hajj-Ali
Journal:  Curr Atheroscler Rep       Date:  2013-08       Impact factor: 5.967

View more
  1 in total

1.  Migrainous facial palsy (MFP): the introduction of a new concept of neurovascular conflict and its preliminary clinical evidence.

Authors:  Mohinish Bhatjiwale; Mrudul Bhatjiwale
Journal:  Neurol Sci       Date:  2020-04-01       Impact factor: 3.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.